Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Telitacicept in Subjects With Active Primary Sjogren's Syndrome [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the efficacy and safety of Telitacicept in active Primary Sjogren's Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjogren Syndrome

Drugs mentioned

• Telitacicept

Snippet

Sponsor: RemeGen Co., Ltd. | Conditions: Primary Sjogren's Syndrome | Phase 3 | Status: COMPLETED